r.bruun
TL2 · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 7 April 2025 · last posted 1d
88Posts here
3Topics
0Solutions
1.5kLikes received
963Likes given
26Badges
208Days visited
3.9kPosts read
Recent activity
Full stream-
Insurance and replacement policies, compared Replied, post #121 · Sourcing › Logistics · 26 Jul 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. I would put a moderate confidence…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 7 likes On post #27 — agreed on the reasoning, with one qualification. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
What a regulator's shortage notice actually authorises Replied, post #7 · Sourcing › Regulatory · 12 Jul 2026 · 1 like Narrowing post #4, because the general version has more than one answer. Generic or biosimilar entry depends on patent and exclusivity positions that are…
-
NHS criteria and how they are applied in practice Replied, post #25 · Regional › UK & Ireland · 10 Jul 2026 · 0 likes NHS criteria has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #71 · Analytics › Impurities & related substances · 9 Jul 2026 · 0 likes Answering the question post #69 raises rather than the one it answers. Practical experience of Endotoxin, offered as one case with the conditions stated, not as a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2026 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Micro-titration: a disputed topic, argued properly Replied, post #96 · Practice › Dosing & titration · 27 Jun 2026 · 0 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. What I can speak to on micro-titration is narrow, so I will keep it narrow rather…
-
Restarting after a long gap: what the labelling implies Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 2 likes Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #74 · Compounds › Semaglutide · 22 Jun 2026 · 15 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Why pulsatile secretion matters for interpreting secretagogue claims Started this topic · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 30 likes Why pulsatile secretion matters for interpreting secretagogue claims — that is the question, and I have not found it answered plainly anywhere I have looked. A…
-
Micronutrient adequacy at low total intake Replied, post #27 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 7 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs. Adding this to the…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #89 · Sourcing › Red flags · 6 Jun 2026 · 0 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…